CRP and atherosclerosis: Originally, CRP was considered to be a nonspecific biomarker of inflammation; however, following ~10 years of investigation, it has been demonstrated that CRP participates in inflammation and atherosclerosis directly and has been indicated to be a prognostic factor and a risk factor (14).